Product guide · Restricted substance
Nucleon Nutrition 5-Amino-1MQ 10 mg
Research compound from Nucleon Nutrition. This guide sets out what the manufacturer states about the composition of Nucleon Nutrition 5-Amino-1MQ 10 mg, what independent research says about its main ingredient, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.
Back to the product- Named ingredients
- 1
- Amounts stated
- All
- Status
- Restricted substance
- Evidence summaries
- 1
Overview
Manufacturer informationNucleon Nutrition 5-Amino-1MQ 10 mg contains 5-Amino-1MQ: 10 mg, as stated in the product title.
Ingredients & composition
Manufacturer information| Ingredient | Amount |
|---|---|
| 5-Amino-1MQ | 10 mg (as stated in the product title) |
Scientific background
Independent research5-Amino-1MQ
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule, not a peptide, that inhibits the enzyme nicotinamide N-methyltransferase (NNMT). It is studied in obesity research1.
Research evidence
Independent research5-Amino-1MQ
The research is in mice with diet-induced obesity1. There are no published human trials.
Evidence limitations
Independent researchNo published study has tested this specific product; the research summarised here concerns the ingredient itself.
5-Amino-1MQ
Effects in humans are unknown.
Safety & potential risks
Independent research5-Amino-1MQ
Human safety data are lacking. Reviewers describe a "gray market" of unapproved peptides sold directly to consumers outside regulatory oversight, with uncertain purity and safety2.
Regulatory status
Contains a synthetic research compound that is not authorised as food (novel food) or as a medicinal product in the EU. No dosing information for human use is provided.
Scientific references
- Dimet-Wiley A, Wu Q, Wiley JT, et al. Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice. Sci Rep. 2022;12:484. PubMed 35013352
- Mendias CL, Awan TM. Safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance. Sports Med. 2026;56:1921-1935. PubMed 41966639
- Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
- Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
- World Anti-Doping Agency. The Prohibited List (current edition). Source
Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.
The product
Nucleon Nutrition 5-Amino-1MQ 10 mg
€44,90 · Sold out